Growth-Hormone Peptides: Do Sermorelin and Ipamorelin Slow Ageing?

Search "anti-ageing peptides" and you'll quickly meet sermorelin, ipamorelin and CJC-1295 — marketed as a gentler, "natural" way to turn back the clock: more muscle, less fat, deeper sleep, a more youthful you, all by coaxing your body to make more of its own growth hormone. It's a seductive pitch, and a clever one, because it sounds more physiological than just injecting hormones. But it leans on an assumption worth examining closely: that raising growth hormone is a good idea in the first place. Here's the honest picture.

What are growth-hormone peptides?

Unlike injecting growth hormone (GH) directly, these peptides are secretagogues — they signal your pituitary gland (a small gland at the base of the brain) to release more of your own growth hormone, in something closer to the body's natural rhythm. They come in two flavours:

• GHRH analogues — copies of the natural "release growth hormone" signal. This group includes sermorelin, CJC-1295 and the one approved drug, tesamorelin.
• Ghrelin mimetics / GH-releasing peptides — a different trigger for the same gland. Ipamorelin is the popular example, often paired with CJC-1295.

The result, in theory, is a rise in growth hormone and the downstream hormone it drives, IGF-1, made mainly by the liver. (For the basics of what a peptide even is, see our peptide guide.)

What's actually approved — and what isn't?

This is where the marketing and the regulation part ways. Of this whole family, only tesamorelin is FDA-approved — and only for a narrow, specific use: reducing excess abdominal fat in people with HIV-associated lipodystrophy ¹². It is not approved for anti-ageing, muscle-building or general weight loss, and its approval doesn't transfer to the other peptides.

The popular "anti-ageing" peptides sit outside that approval entirely. Sermorelin was once available as an approved branded medicine and is today supplied mainly through compounding pharmacies. Ipamorelin and CJC-1295 are not FDA-approved for any indication — they're used off-label or, increasingly, sold as unregulated "research" peptides with the same sourcing and purity concerns we cover for BPC-157. So while there are more than 80 approved peptide medicines in the world ³, most of the ones in an anti-ageing "GH peptide stack" aren't among them.

Does "more growth hormone" actually slow ageing?

Here's the question the whole category quietly skips — and the most important one. It's true that growth hormone naturally declines with age, and it's tempting to conclude that "topping it back up" must be rejuvenating. But that logic doesn't hold, and the science points the other way:

• There are no good human trials showing GH peptides slow ageing or extend healthy lifespan. The anti-ageing claim is essentially unproven.
• In longevity research, lower growth-hormone and IGF-1 signalling is repeatedly linked to longer life in animals — the opposite of the marketing premise. The decline with age may be partly protective, not simply a deficiency to "fix".
• Too much growth hormone is clearly harmful. The condition of GH excess (acromegaly) causes serious problems — which is a strong hint that more is not automatically better.

In other words, the foundational assumption — that raising a hormone which falls with age must be good — is exactly the kind of intuition that healthy-ageing science has learned to distrust. It's the same trap we describe around the hallmarks of ageing and molecules like NAD+: a real biological change with age does not mean reversing it is safe or beneficial.

The safety and sourcing problem

Even setting the big question aside, raising growth hormone isn't free of downsides. Reported effects include fluid retention, joint aches, numbness or tingling (carpal tunnel-type symptoms), and — importantly — rises in blood sugar and insulin resistance, since growth hormone opposes insulin. There's also a long-standing theoretical concern about IGF-1 and cancer growth that means caution is warranted, particularly for anyone with a cancer history. Layer on the reality that many of these peptides are bought from unregulated sources at guessed doses, and the risk-to-evidence balance looks poor.

What we see at the clinic

A familiar visitor is someone in their 40s or 50s, feeling the ordinary effects of ageing, who's been told a GH peptide stack will rebuild their body. We try to reframe the conversation honestly: the thing being sold — higher growth hormone — isn't a proven longevity lever, and may not even point in the helpful direction. We're much more interested in the levers that are proven: strength training (which does more for age-related muscle loss than any peptide), sleep, protein, metabolic health, and checking the hormones that genuinely warrant attention — for men, that sometimes means an honest look at testosterone, measured properly rather than guessed. Chasing growth hormone is rarely the answer to the question people are actually asking.

Common questions

Are growth-hormone peptides the same as taking HGH? No. Injectable human growth hormone adds the hormone directly; these peptides instead prompt your own pituitary to release more. The end goal — higher GH — is similar, and so are many of the concerns.

Is sermorelin or ipamorelin FDA-approved for anti-ageing? No. Only tesamorelin is FDA-approved, and only for HIV-associated lipodystrophy ¹². Sermorelin, ipamorelin and CJC-1295 are not approved for anti-ageing or muscle building.

Will they make me more muscular and youthful? There's no solid human evidence that these peptides deliver meaningful anti-ageing or body-composition benefits, and "more growth hormone" isn't a proven path to longer, healthier life. Resistance training has far better evidence for preserving muscle as you age.

Are they safe? Raising growth hormone can cause fluid retention, joint pain and worsened blood sugar, with theoretical longer-term concerns. Combined with unregulated sourcing, the safety picture is genuinely uncertain — a reason for real caution, not reassurance.

Key takeaway

Growth-hormone peptides like sermorelin, ipamorelin and CJC-1295 are marketed as a natural anti-ageing upgrade, but the foundation is shakier than the pitch suggests. Only tesamorelin is approved, and only for a specific HIV-related condition; the anti-ageing claims are essentially untested in humans; and "more growth hormone" is not an established way to slow ageing — if anything, lower signalling is linked to longer life in animals. Add unregulated sourcing and real side effects, and the case weakens further. The proven path to ageing well still runs through the unglamorous foundations, not a vial.